Publications by authors named "Megan M Dulohery Scrodin"
Patients with advanced emphysema frequently experience severe dyspnea that is inadequately treated with medical therapy alone. Over the past 4 years, we have seen increased usage of bronchoscopic lung volume reduction (BLVR) with endobronchial valves. Success of the procedure is dependent on patient selection because it is not necessarily appropriate for all patients with severe emphysema.
View Article and Find Full Text PDFArticle Synopsis
- Ventilatory inefficiency during exercise in COPD patients can result from respiratory muscle issues or difficulty with airflow, leading to air-trapping and hyperinflation.
- The text presents a case involving a patient experiencing severe exercise-related ventilatory limitations due to decreased respiratory muscle mass from gender-affirming hormone therapy (GAHT).
- It highlights the need to consider how GAHT may affect pulmonary function tests (PFT) and respiratory symptoms in transgender and gender diverse (TGD) individuals.
There is increasing evidence that sex hormones may impact the development of obstructive lung disease (OLD). Therefore, we studied the effect of bilateral oophorectomy (oophorectomy) on the development of OLD. Women were identified from the Mayo Clinic Cohort Study of Oophorectomy and Aging-2.
View Article and Find Full Text PDFIntroduction: Bronchoscopic lung volume reduction (BLVR) with endobronchial valves (EBVs) has emerged as an important treatment method for patients with severe chronic obstructive pulmonary disease (COPD). Acute exacerbations of COPD (AECOPD) are a frequent complication following BLVR with EBV. However, there is no consensus on the prevention of AECOPD.
View Article and Find Full Text PDF